Clinical trials
Observational Atrial Fibrillation trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Unknown status | 15 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 8 |
| Boehringer Ingelheim | 8 |
| Bayer | 6 |
| Medtronic Cardiac Ablation Solutions | 6 |
| Boston Scientific Corporation | 4 |
| Hospital Clinic of Barcelona | 4 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 3 |
| Centro Medico Teknon | 2 |
| Felipe Atienza | 2 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 82 |
| Stroke | 18 |
| Arrhythmias, Cardiac | 9 |
| Ischemic Stroke | 6 |
| Hemorrhage | 5 |
| Thromboembolism | 4 |
| Heart Failure | 3 |
| Bradycardia | 2 |
| Cardiomyopathies | 2 |
| Embolism | 2 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.